USA Health Homepage

Navigation

Susan Baker

Susan L. Baker, M.D.

Maternal-Fetal PhysicianDirector of Maternal Fetal Medicine Division; Associate Professor of Obstetrics and GynecologySpecialty: Pregnancy & Childbirth, Women's Care
Refer a Patient
Request an Appointment
Or call to make an appointment1 (251) 415-1496

Conditions Treated

  • Genetic Disorder
  • Gestational Diabetes
  • High-Risk OB

Board Certifications

  • American Board of Obstetrics and Gynecology

Education

  • Medical School: University of Alabama at Birmingham | Birmingham, AL
  • Residency: University of Alabama at Birmingham | Birmingham, AL
  • Fellowship: University of Alabama at Birmingham | Birmingham, AL

Languages

  • English

Locations

Clinical Trials

14-221 - Specimen Collection From Pregnant Women at Increased Risk for Fetal AneuploidyStatus: open

Collection of Whole Blood Specimens from Pregnant Women at Increased Risk for Fetal Chromosomal Abnormality for use in Development of a Noninvasive Prenatal Test in Detection of the Relative Quantity of Chromosomal Material in Circulating Cell-Free DNA Extracted From Maternal Plasma

Treatment for Fetal Aneuploidy / Down Syndrome

Children's & Women's Hospital
1700 Center Street
Mobile, AL 36604
Learn More
251-415-1598
15-235 - Impact of a Booster Course of Antenatal Steroids on Neonatal Outcome in Patients With Premature Rupture of the MembranesStatus: open

A Randomized Double-Blinded Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids on Neonatal Outcome in Patients with Prelabor Premature Rupture of Membranes

Treatment for Premature Rupture of Membranes

Children's & Women's Hospital
1700 Center Street
Mobile, AL 36604
Learn More
251-415-1598
18-108 - Chronic Hypertension in Pregnancy (CHAP)Status: open

A Pragmatic Multicenter Randomized Clinical Trial (RCT) of Antihypertensive Therapy for Mild Chronic Hypertension During Pregnancy: Chronic Hypertension and Pregnancy (CHAP) Project

Treatment for Pulmonary Arterial Hypertension

Strada Patient Care Center
1601 Center Street
Mobile, AL 36604
Learn More
251-415-1598
17-019 - Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe PreeclampsiaStatus: open

A Phase 2b/3a, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of AMAG-423, a Digoxin Immune Fab, in Antepartum Subjects With Severe Preeclampsia

Treatment for Preeclampsia

Children's & Women's Hospital
1700 Center Street
Mobile, AL 36604
Learn More
251-415-1598
This link will open in a new tab or window.